Mike Sussman, longtime director of the UW–Madison Biotechnology Center, has announced that he is stepping down from that position to serve as director of the genome center. Chris Bradfield has been named interim Biotechnology Center director.
Scientists at the Morgridge Institute for Research have discovered a promising new target to fight a class of viruses responsible for health threats such as Zika, polio, dengue, SARS and hepatitis C.
A new study shows an improved tactic for delivering new genes into the eye's drain, called the trabecular meshwork, offering a promising treatment for glaucoma.
“Most young people with Friedreich’s ataxia develop severe heart problems and are wheelchair-bound," says researcher Aseem Ansari, "but the disease is so rare that few drug companies invest in it."
Jason Fletcher is researching how public policy intersects with genetic data, what our genes can predict about how society functions, and how we should use this data responsibly — an area of study dubbed "social genomics."
Pictures obtained from Ahna Skop’s exploration of the cell — as well as striking images from other UW–Madison research projects — will serve as a basis for a traveling art exhibit, “Genetic Reflections.”
Scientists at the University of Wisconsin–Madison’s Waisman Center have shown one way in which human genetics and chronic stress interact to shape health and well-being later in life.
Biochemists from the University of Wisconsin–Madison and the Max Planck Institute (MPI) for Biophysical Chemistry in Germany have revealed the defined architecture of what is called the “expressome.”
Fred Blattner has been doing DNA research for more than 50 years, and he founded or co-founded three successful companies all focused on DNA: DNASTAR, Nimblegen and Scarab Genomics.
A UW–Madison program built around plants that mature quickly enough to engage the scientific curiosity of elementary through college students is releasing two new varieties that make the popular plants even better suited to classrooms.
James Steele’s new company, Lactic Solutions, is advancing a judo-like remedy: using genetic engineering to transform enemy into friend.